JXSB2200073 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200074 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200075 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200076 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200077 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200078 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200079 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200080 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200081 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-06-16 | | Novo Nordisk A/S | | | view |
JXSB2200139 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200140 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200141 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200142 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200143 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200144 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200145 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200146 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSB2200147 | Mim8 | denecimig | Injection | Biological Products(1) | Supplementary Application | 2022-10-29 | | Novo Nordisk A/S | | | view |
JXSL2100031 | Mim8 | denecimig | Injection | Biological Products(1) | Import Drug Application | 2021-02-26 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2021-02-25 | view |
JXSL2100032 | Mim8 | denecimig | Injection | Biological Products(1) | Import Drug Application | 2021-02-26 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2021-02-25 | view |